Patent Assignment
Reel/Frame 047321/0235
Employment Agreement
Recorded: 2018-09-19
Pages: 17
Assignor
CHO, ROBERT
Executed: 2010-10-11
Assignee
QUANTICEL PHARMACEUTICALS, INC
9393 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(3)
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Patent:
10,328,077 →
Application:
15/673,084 →
Publication:
US 2018/0125844
PCT:
PCT/US2017/046098 ↗
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application:
62/373,263 →
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application:
62/468,424 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 19, 2016
From: XU, JIANGCHUN; CHO, ROBERT; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 039484/0664 →
Assignment of Assignor's Interest
Mar 21, 2017
From: XU, JIANGCHUN; CHO, ROBERT; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 041658/0071 →
Assignment of Assignor's Interest
Apr 5, 2018
From: XU, JIANGCHUN; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 045452/0543 →
Assignment of Assignor's Interest
Sep 19, 2018
From: QUANTICEL PHARMACEUTICALS, INC.
To: CELGENE CORPORATION
Reel/Frame 046912/0972 →
Assignment of Assignor's Interest
Nov 11, 2019
From: CELGENE CORPORATION
To: CELGENE QUANTICEL RESEARCH, INC.
Reel/Frame 050974/0894 →